Drug Shortage Report for ROTATEQ
Report ID | 44836 |
Drug Identification Number | 02284413 |
Brand name | ROTATEQ |
Common or Proper name | rotavirus vaccine, live, oral, pentavalent oral solution |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1 |
Strength(s) | 2210000UNIT 2840000UNIT 2220000UNIT 2040000UNIT 2290000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | ORAL |
Packaging size | 1DOSE TUBE |
ATC code | J07BH |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-04-03 |
Actual start date | 2018-04-03 |
Estimated end date | 2018-04-20 |
Actual end date | 2018-04-17 |
Shortage status | Resolved |
Updated date | 2018-04-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-04-18 | French | Compare |
v4 | 2018-04-18 | English | Compare |
v3 | 2018-04-13 | English | Compare |
v2 | 2018-04-03 | French | Compare |
v1 | 2018-04-03 | English | Compare |
Showing 1 to 5 of 5